Amanote Research

Amanote Research

    RegisterSign In

Irisin: As a Therapeutic Target for Metabolic Disorders

Journal of Endocrinology and Metabolism - Canada
doi 10.14740/jem528w
Full Text
Open PDF
Abstract

Available in full text

Categories
EndocrinologyMetabolismDiabetes
Date

January 1, 2018

Authors
Ikram Ullah Khan
Publisher

Elmer Press, Inc.


Related search

GABAergic Signaling as Therapeutic Target for Autism Spectrum Disorders

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2014English

The Potential of Oxytocin as a Therapeutic Target for Psychiatric Disorders

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2016English

The Molecular Chaperone GRP78/BiP as a Therapeutic Target for Neurodegenerative Disorders: A Mini Review

Journal of Genetic Syndromes & Gene Therapy
2013English

LncRNA as a Therapeutic Target for Angiogenesis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2017English

Tau: A Common Denominator and Therapeutic Target for Neurodegenerative Disorders

Journal of Experimental Neuroscience
Neuroscience
2018English

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

The Brain H3-Receptor as a Novel Therapeutic Target for Vigilance and Sleep–wake Disorders

Biochemical Pharmacology
BiochemistryPharmacology
2007English

CD38 as a Therapeutic Target

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2006English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy